Steadview Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Precision NeuroscienceinApr 2021
HealthtechNew York, US
Benjamin Rapoport(President, Chief Science Officer)Michael Mager(Chief Executive Officer)Craig Mermel(President and Chief Product Officer)MIchael Kaswan(Chief Financial Officer)
BoardEric M. Attias(Director)Howard Morgan(Director)in
Co-investorsAlumni VenturesB Capital GroupBasecamp FundSCI VenturesForepont Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.